期刊文献+

稳定扩张性心肌病患者中血浆B型利钠肽和肾素浓度的相互关系 被引量:1

Relationship between BNP level and PRC of patients with stable dilated cardiomyopathy
原文传递
导出
摘要 目的研究B型利纳肽(B-type natriuretic peptide,BNP)生物学变异是否体现稳定慢性心力衰竭(chronicheart failure,CHF)患者疾病进程。方法比较存在扩张性心肌病(dilated cardiomyopathy,DCM)的稳定CHF患者中BNP和肾素-血管紧张素醛固酮系统(renin-angiotensin-aldosterone system,RAS)因子生物学变量。存在DCM稳定CHF患者80例,测定BNP和RAS因子。结果经梯式多变量分析,血清BNP在基线水平(P=0.005)、存在房颤(P=0.014)、高血浆肾素浓度(plasma renin concentration,PRC)(PRC,P=0.002)是显著性独立优势因子,与高BNP相关。随访2个月,无体重和血压的改变,血细胞比容变化(%)与BNP变化不相关(r=-0.325,P=0.000 7),却与PRC变化相关(r=0.680,P=0.001)。结论 BNP生物学变异与PRC生物学变异显著相关,提示在脑利钠肽系统与RAS系统存在生理学相互作用,导致在DCM患者中发生BNP的生物学变异。 Objective To interpret B-type natriurenic peptide(BNP)level in patients with stable chronic heart failure {CHF) and to learn whether the change in BNP represents disease progression. Methods To compare change in BNP and biological variation in factors of the renin angiotensin aldosterone system(RAS} in stable CHF patients with dilated cardiomyopathy(DCM) ,the level of BNP and RAS factors were measured in 80 stable DCM patients. Results According to stepwise multivariate analysis,serum BNP at baseline(P=0. 005), presence of atrial fibrilla- tion(P=0. 014), a high biological variation in plasma renin concentration { PRC, P= 0. 002 ) were significant inde- pendent dominant factors related to a high biological variation in BNP. Although there was no change in body weight or blood pressure during the 2 months following up study period,the change in hematocrit( % ) was negatively corre- lated with the change in BNP( % )( r=- 0. 325, P=0. 000 7 ) and positively correlated with the change in PRC( r= 0. 680, P= 0. 001 ). Conclusions There is significant relationship between biological variation in BNP and biologicao variation in PRC, suggesting that the physiological interaction between natriuretic peptide system and RAS may con- tribute to the biological variation in BNP in stable DCM patients.
出处 《中国误诊学杂志》 CAS 2012年第9期2025-2027,共3页 Chinese Journal of Misdiagnostics
关键词 心肌病 扩张型/代谢 心钠素/代谢 肾素/代谢 Cardiomyopathy, dilated/metabolism Atrial natriuretic factor/metabolism Renin/metabolism
  • 相关文献

参考文献5

  • 1Masson S,Latini R,Anand IS. Direct comparison of Btype natriuretic peptide(BNP)and aminoterminal proBNP in a large population of patients with chronic and symptomatic heart failure:The Valsartan Heart Failure(Val-HeFT)data[J].Clinical Chemistry,2006,(08):1528-1538.doi:10.1373/clinchem.2006.069575.
  • 2Tanino Y,Shite J,Paredes OL. Whole body bioimpedance monitoring for outpatient chronic heart failure follow up[J].Circulation,2009,(06):1074-1079.
  • 3Bruins S,Fokkema MR,Romer JW. High intraindividual variation of B-type natriuretic peptide(BNP)and amino-terminal proBNP in patients with stable chronic heart failure[J].Clinical Chemistry,2004,(11):2052-2058.doi:10.1373/clinchem.2004.038752.
  • 4Jessup M,Abraham WT,Casey DE. 2009 focused update:ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults:A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines:Developed in collaboration with the International Society for Heart and Lung Transplantation[J].Circulation,2009,(14):1977-2016.
  • 5Nishiyama K,Tsutamoto T,Yamaji M. Biological variation of brain natriuretic peptide and cardiac events in stable outpatients with nonischemic chronic heart failure[J].Circulation,2011,(02):341-347.

同被引文献6

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部